Company research / ADMA
ADMA Biologics, Inc. (ADMA)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, ADMA Biologics, Inc. reported revenue of $510.17M. Revenue grew 19.6% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $512.27M.
Key ratios (year ended 2025-12-31)
57.4%
Gross margin
37.5%
Operating margin
28.8%
Net margin
30.8%
Return on year-end equity
19.6%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.